Oncology & Cancer

Experts present triple-negative breast cancer immunotherapy trial

A researcher from University Hospitals Seidman Cancer Center will discuss his upcoming immunotherapy clinical trial for triple-negative breast cancer at the 2016 San Antonio Breast Cancer Symposium. The annual symposium is ...

Oncology & Cancer

The key to determining the right treatment for breast cancer

The Comprehensive Cancer Center (CCC) of MedUni Vienna and Vienna General Hospital has received the highest accolade for its research work in the field of breast cancer: top medical journal The Lancet commissioned Michael ...

Oncology & Cancer

Study tests new breast cancer drug in African American women

The first clinical trial to test a newly approved breast cancer drug specifically in African American patients is now enrolling at Georgetown Lombardi Comprehensive Cancer Center and will begin soon at five other institutions ...

Oncology & Cancer

Gene mutation 'hotspots' linked to better breast cancer outcomes

Kataegis is a recently discovered phenomenon in which multiple mutations cluster in a few hotspots in a genome. The anomaly was previously found in some cancers, but it has been unclear what role kataegis plays in tumor development ...

Oncology & Cancer

New target identified for reducing cancer metastasis

A protein that is constantly expressed by cancer cells and quiescent in healthy ones appears to be a solid target for reducing cancer's ability to spread, scientists report.

page 4 from 12